CRIS Q2 2022 Earnings — Curis, Inc. Revenue & Financial Results | Market Cap Arena

CRISCuris, Inc.

$14M

Q2 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M+4.7% YoY

Gross Profit

$2M98.2% margin

Operating Income

-$15M-629.4% margin

Net Income

-$16M-666.1% margin

EPS (Diluted)

$-3.48

QoQ Revenue Growth

+16.3%

Cash Flow

Operating Cash Flow

-$12M

Free Cash Flow

-$12M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$129M

Total Liabilities

$67M

Stockholders' Equity

$62M

Cash & Equivalents

$34M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$2M	+4.7%
Gross Profit	$2M	$2M	+8.3%
Operating Income	-$15M	-$11M	-41.4%
Net Income	-$16M	-$11M	-47.1%

Revenue Segments

Gross Royalty Revenue

$2M103%

Contra Revenue

-$81,000-3%